Format

Send to

Choose Destination
Redox Rep. 2015 Jan;20(1):33-41. doi: 10.1179/1351000214Y.0000000101. Epub 2014 Aug 13.

Oxidative stress and antioxidant status in patients with autoimmune liver diseases.

Abstract

OBJECTIVE:

To estimate oxidative stress and antioxidant components during different stages of autoimmune liver diseases and assess their possible implication on disease progression.

METHODS:

We determined several markers of oxidative injury (isoprostane, aldehydes, protein carbonyls, 3-nitrotyrosine, and myeloperoxidase) and antioxidant components (glutathione, glutathione peroxidase, glutathione reductase, superoxide dismutase, and catalase) in whole blood, serum, and urine in 49 patients with autoimmune cholestatic liver diseases (AC) and 36 patients with autoimmune hepatitis (AIH) and healthy subjects matched for sex and age.

RESULTS:

Both AC and AIH patients had increased levels of all lipid and protein oxidative injury products and significantly decreased whole blood glutathione levels compared to controls. AIH patients had significantly higher levels of aldehydes and glutathione peroxidase activity and significantly lower protein carbonyl levels compared to AC patients. Protein carbonyl and isoprostane levels increased and glutathione levels decreased gradually with progression from mild fibrosis to severe fibrosis and cirrhosis in both AC and AIH patients. In addition, both cirrhotic AC and AIH patients had significantly higher protein carbonyls compared to non-cirrhotics.

DISCUSSION:

We provide novel findings in support of a major contribution of oxidant/antioxidant imbalance in the progression of liver injury in AC and AIH.

KEYWORDS:

Antioxidant enzymes; Autoimmune hepatitis; Glutathione; Lipid peroxidation; Primary biliary cirrhosis; Protein carbonyls

PMID:
25117650
DOI:
10.1179/1351000214Y.0000000101
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center